Ladenburg Thalmann Financial Services’s Kyntra Bio KYNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$105K Sell
98
-39
-28% -$39.8K ﹤0.01% 2976
2019
Q3
$127K Buy
137
+1
+0.7% +$1.1K ﹤0.01% 2775
2019
Q2
$154K Sell
136
-14
-9% -$15.3K ﹤0.01% 2653
2019
Q1
$205K Buy
150
+20
+15% +$27.1K ﹤0.01% 2376
2018
Q4
$150K Buy
130
+41
+46% +$46.1K ﹤0.01% 2450
2018
Q3
$135K Sell
89
-3
-3% -$4.62K ﹤0.01% 2601
2018
Q2
$107K Hold
92
﹤0.01% 2702
2018
Q1
$107K Buy
92
+1
+1% +$1.32K ﹤0.01% 2702
2017
Q4
$108K Buy
91
+7
+8% +$8.78K ﹤0.01% 2667
2017
Q3
$113K Sell
84
-1
-1% -$1.05K ﹤0.01% 2510
2017
Q2
$68K Buy
85
+1
+1% +$697 ﹤0.01% 2788
2017
Q1
$51K Buy
84
+1
+1% +$609 ﹤0.01% 2893
2016
Q4
$45K Sell
83
-2
-2% -$999 ﹤0.01% 2919
2016
Q3
$45K Buy
85
+4
+5% +$1.88K ﹤0.01% 2851
2016
Q2
$33K Sell
81
-1
-1% -$458 ﹤0.01% 2992
2016
Q1
$43K Sell
82
-2
-2% -$997 ﹤0.01% 2706
2015
Q4
$64K Hold
84
﹤0.01% 2387
2015
Q3
$46K Sell
84
-4
-5% -$2.42K ﹤0.01% 2526
2015
Q2
$52K Buy
88
+83
+1,660% +$48.3K ﹤0.01% 2556
2015
Q1
$4K Buy
+5
New +$3.88K ﹤0.01% 4060

Other funds holding KYNB

Ladenburg Thalmann Financial Services's KYNB Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its Kyntra Bio (KYNB) stake by 28% in Q4 2019, selling an estimated $39.8K and leaving 98 shares worth $105K. The position accounts for ﹤0.01% of the portfolio, ranked #2976.

Ladenburg Thalmann Financial Services first reported a position in KYNB in Q1 2015 and has held it in 20 quarters since. The position peaked at $205K in Q1 2019. 213 funds tracked by Wall St. Rank hold KYNB as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 98 shares of Kyntra Bio worth $105K as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 39 Kyntra Bio shares in Q4 2019, an estimated $39.8K.
  • Kyntra Bio made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #2976 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Kyntra Bio in Q1 2015 and has held it in 20 quarters since.
  • Ladenburg Thalmann Financial Services's Kyntra Bio position peaked at $205K in Q1 2019.
  • 213 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.